tetano
Editor, Senior Moderator
J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16579. [Epub ahead of print]
Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.
Ehsani AH[SUP]1[/SUP], Nasimi M[SUP]1[/SUP], Bigdelo Z[SUP]2[/SUP].
Author information
Abstract
Cutaneous manifestation has been reported in 0.2% of patients infected by COVID-19 in China, and 18 out of 88 patients from Italy. The most commonly reported features are exanthomatous rash, urticaria, chickenpox like vesicles, petechiae, and acute hemorrhagic edema of infancy. Herein, we report one case of pityriasis rosea in a patient infected with COVID-19.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; Pityriasis rosea; coronavirus; cutaneous
PMID:32359180DOI:10.1111/jdv.16579
Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.
Ehsani AH[SUP]1[/SUP], Nasimi M[SUP]1[/SUP], Bigdelo Z[SUP]2[/SUP].
Author information
Abstract
Cutaneous manifestation has been reported in 0.2% of patients infected by COVID-19 in China, and 18 out of 88 patients from Italy. The most commonly reported features are exanthomatous rash, urticaria, chickenpox like vesicles, petechiae, and acute hemorrhagic edema of infancy. Herein, we report one case of pityriasis rosea in a patient infected with COVID-19.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; Pityriasis rosea; coronavirus; cutaneous
PMID:32359180DOI:10.1111/jdv.16579